Protagonist Therapeutics, Inc. (PTGX)
92.24
+0.86
(+0.95%)
USD |
NASDAQ |
Dec 11, 16:00
92.24
0.00 (0.00%)
After-Hours: 18:17
Protagonist Therapeutics Free Cash Flow: 63.71M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Johnson & Johnson | 20.46B |
| ADMA Biologics, Inc. | 40.61M |
| Regeneron Pharmaceuticals, Inc. | 3.881B |
| Vanda Pharmaceuticals, Inc. | -82.95M |
| Bristol Myers Squibb Co. | 15.30B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -1.937M |
| Cash from Investing (Quarterly) | -58.56M |
| Cash from Financing (Quarterly) | 5.659M |
| Free Cash Flow Per Share (Quarterly) | -0.0318 |
| Free Cash Flow to Equity (Quarterly) | -1.495M |
| Free Cash Flow to Firm (Quarterly) | -2.025M |
| Free Cash Flow Yield | 1.08% |